Keywords: Pfizer, Diflucan, USA, FDA, Birth defects, Pregnancy
US FDA warns high-dose of Pfizer’s Diflucan during pregnancy may cause birth defects
Article | 07 August 2011
The US Food and Drug Administration has warned that treatment with chronic, high doses (400-800mg/day) of drug behemoth ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Pfizer to split-off remaining 80% interest in Zoetis
